Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/0NnxAZoPRpA/265430.php
Saturday 31 August 2013
Alcon receives positive recommendation from NICE Appraisal Committee for use of Jetrea� in patients with vitreomacular traction and macular hole
Alcon, the global leader in eye care, is pleased that the National Institute for Health and Care Excellence (NICE) Appraisal Committee has delivered a positive Final Appraisal Determination (FAD) for Jetrea�, recommending its use to treat adults with vitreomacular traction including macular hole of less than or equal to 400 microns when an epiretinal membrane is absent, or adults with vitreomacular traction and severe symptoms when an epiretinal membrane and macular hole are both absent...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment